Company Profile
Mega Genomics Limited, a genetic testing platform company offers consumer genetic testing and cancer screening services in China. It offers brain health assessment package, a service that assesses the risk of various related diseases, including Alzheimer's disease.
Its portfolio also includes alimentation capability assessment package, a service that assesses the risk of developing hyperhomocysteinemia, Parkinson's disease risk assessment, full-scale cancer risk assessment packages, myocardial infarction and heart failure genetic testing, cardiovascular and cerebrovascular disease risk assessment packages, hereditary breast cancer/ovarian cancer genetic testing, Septin9 colorectal cancer screening test, RNF180/Septin9 gastric cancer screening test, cervical cancer genetic methylation testing, a cervical cancer test, telomere length genetic testing, and personal whole genome test plus, a service that assesses the risk of developing multiple types of diseases and provides interpretation for various individual traits and medication advice, as well as whole exome sequencing package for adults, a service that assesses the risk of developing multiple high-risk diseases, hereditary cancers, recessive genetic diseases, and types of complex diseases, as well as multiple drugs, dietary nutrition items, and exercise and fitness items.
Its portfolio also includes folate metabolic capacity assessment testing kits to assess the risk of developing cardiovascular and cerebrovascular diseases, ApoE gene testing for testing Alzheimer's disease, BRCA1/2 gene mutation testing kits, Alzheimer's disease screening kits, colorectal cancer screening kits, gastric cancer screening kits, lung nodule auxiliary diagnostic kits, and cervical cancer screening kits to health checkup centers and hospitals. Founded in 2016, the company is headquartered in Beijing, China.